Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane

Reitz, RH; Mccroskey, PS; Park, CN; Andersen, ME; Gargas, ML

HERO ID

94806

Reference Type

Journal Article

Year

1990

Language

English

PMID

2392805

HERO ID 94806
In Press No
Year 1990
Title Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane
Authors Reitz, RH; Mccroskey, PS; Park, CN; Andersen, ME; Gargas, ML
Journal Toxicology and Applied Pharmacology
Volume 105
Issue 1
Page Numbers 37-54
Abstract A six compartment physiologically based pharmacokinetic (PB-PK) model was developed to describe the disposition of diethylene-1,4-dioxide (dioxane) and its principal metabolite beta-hydroxyethoxyacetic acid in rats, mice, and humans. The model was developed from experimentally measured partition coefficients (reported here for the first time) as well as pharmacokinetic data previously reported. The completed PB-PK model adequately described data from gavage and intravenous studies in rats, as well as inhalation studies in rats and humans. Substantial nonlinearities were observed in the kinetic behavior of dioxane under high exposure conditions (water concentrations greater than 0.1% dioxane and atmospheric concentrations greater than 300 ppm dioxane). The PB-PK model was subsequently used to prepare quantitative estimates of the "plausible upper bounds" on carcinogenic risk for human populations exposed to dioxane in air or water. Based on these quantitative estimates, it appears that human populations continuously exposed to 740-3700 ppb dioxane in air or 20,000-120,000 ppb dioxane in water would be unlikely to experience increased frequencies of tumors.
Doi 10.1016/0041-008X(90)90357-Z
Pmid 2392805
Wosid WOS:A1990DX33600005
Url https://linkinghub.elsevier.com/retrieve/pii/0041008X9090357Z
Is Certified Translation No
Dupe Override No
Comments Journal: TOXICOL APPL PHARM ISSN:
Is Public Yes
Language Text English
Keyword Animals; Carcinogens, Environmental/pharmacokinetics; Computer Simulation; Dioxanes/administration & dosage/pharmacokinetics/toxicity; Dioxins/pharmacokinetics; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Humans; Liver Neoplasms/chemically induced; Liver Neoplasms, Experimental/chemically induced; Male; Mice; Models, Biological; Rats; Risk; Solubility; 0 (Carcinogens, Environmental); 0 (Dioxanes); 0 (Dioxins); 123-91-1 (1,4-dioxane)
Is Qa No